These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 14610685)
1. The role of MRI in patients with astrocytoma WHO II treated with fractionated stereotactic radiotherapy. Plathow C; Lichy MP; Bachert P; Zuna I; Kauczor HU Eur Radiol; 2004 Apr; 14(4):679-85. PubMed ID: 14610685 [TBL] [Abstract][Full Text] [Related]
3. Fractionated stereotactic radiotherapy in low-grade astrocytomas: long-term outcome and prognostic factors. Plathow C; Schulz-Ertner D; Thilman C; Zuna I; Lichy M; Weber MA; Schlemmer HP; Wannenmacher M; Debus J Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):996-1003. PubMed ID: 14575830 [TBL] [Abstract][Full Text] [Related]
4. Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence. Fuss M; Wenz F; Scholdei R; Essig M; Debus J; Knopp MV; Wannenmacher M Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):53-8. PubMed ID: 10924971 [TBL] [Abstract][Full Text] [Related]
5. Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma. Keles GE; Chang EF; Lamborn KR; Tihan T; Chang CJ; Chang SM; Berger MS J Neurosurg; 2006 Jul; 105(1):34-40. PubMed ID: 16871879 [TBL] [Abstract][Full Text] [Related]
6. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI. Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120 [TBL] [Abstract][Full Text] [Related]
8. Fractionated stereotactic radiation therapy in the management of primary oligodendroglioma and oligoastrocytoma. Combs SE; Schulz-Ertner D; Thilmann C; Edler L; Debus J Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):797-802. PubMed ID: 15936562 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of magnetic resonance imaging-guided stereotactic biopsy in the evaluation of recurrent malignant astrocytoma compared with a lesion due to radiation effect. McGirt MJ; Bulsara KR; Cummings TJ; New KC; Little KM; Friedman HS; Friedman AH J Neurosurg; 2003 Jan; 98(1):14-20. PubMed ID: 12546347 [TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging changes after stereotactic radiation therapy for childhood low grade astrocytoma. Bakardjiev AI; Barnes PD; Goumnerova LC; Black PM; Scott RM; Pomeroy SL; Billett A; Loeffler JS; Tarbell NJ Cancer; 1996 Aug; 78(4):864-73. PubMed ID: 8756383 [TBL] [Abstract][Full Text] [Related]
16. Long term course of WHO grade II astrocytomas of the Insula of Reil after I-125 interstitial irradiation. Mehrkens JH; Kreth FW; Muacevic A; Ostertag CB J Neurol; 2004 Dec; 251(12):1455-64. PubMed ID: 15645344 [TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of high-precision radiotherapy in patients with brain stem gliomas: results from a difficult-to-treat patient population using fractionated stereotactic radiotherapy. Combs SE; Steck I; Schulz-Ertner D; Welzel T; Kulozik AE; Behnisch W; Huber PE; Debus J Radiother Oncol; 2009 Apr; 91(1):60-6. PubMed ID: 19285356 [TBL] [Abstract][Full Text] [Related]
19. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases. Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597 [TBL] [Abstract][Full Text] [Related]
20. 5-year survival and clinical prognostic factors in progressive supratentorial diffuse "low-grade" astrocytoma: a retrospective analysis of 46 cases. Schuurman PR; Troost D; Verbeeten B; Bosch DA Acta Neurochir (Wien); 1997; 139(1):2-7. PubMed ID: 9059704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]